Viridian Therapeutics Inc. (VRDN)
NASDAQ · Healthcare
Viridian Therapeutics Inc. Total Liabilities 2013–2025
Viridian Therapeutics Inc. annual total liabilities history from 2016 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Viridian Therapeutics Inc. total liabilities as of December 31, 2025: 177.3M, a 150.48% increase year-over-year.
- Viridian Therapeutics Inc. total liabilities for 2025 were 177.3M, a 150.48% increase from 2024.
- Viridian Therapeutics Inc. total liabilities for 2024 were 70.8M, a 46.20% increase from 2023.
- Viridian Therapeutics Inc. total liabilities for 2023 were 48.4M, a 20.92% increase from 2022.
- Viridian Therapeutics Inc. total liabilities for 2022 were 40.0M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Viridian Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $177 |
| 2024 | $71 |
| 2023 | $48 |
| 2022 | $40 |
| 2021 | $16 |
| 2020 | $11 |
| 2019 | $15 |
| 2018 | $15 |
| 2017 | $14 |
| 2016 | $10 |
Viridian Therapeutics Inc. Total Liabilities — FAQ
Viridian Therapeutics Inc. (VRDN) total liabilities over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VRDN's total liabilities history?
The chart and table above show Viridian Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.